Therapeutically harnessing extracellular vesicles

L Cheng, AF Hill - Nature Reviews Drug Discovery, 2022 - nature.com
The field of extracellular vesicle (EV) research has developed rapidly over the last decade
from the study of fundamental biology to a subject of significant clinical relevance. The …

Bacterial outer membrane vesicles as a platform for biomedical applications: An update

M Li, H Zhou, C Yang, Y Wu, X Zhou, H Liu… - Journal of Controlled …, 2020 - Elsevier
Outer membrane vesicles (OMVs) are produced by Gram-negative bacteria both in vitro and
in vivo. OMVs are nano-sized spherical vehicles formed by lipid bilayer membranes and …

Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study

H Petousis-Harris, J Paynter, J Morgan, P Saxton… - The Lancet, 2017 - thelancet.com
Background Gonorrhoea is a major global public health problem that is exacerbated by drug
resistance. Effective vaccine development has been unsuccessful, but surveillance data …

[HTML][HTML] The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination

SR Parikh, H Campbell, JA Bettinger, LH Harrison… - Journal of Infection, 2020 - Elsevier
Neisseria meningitidis is a major cause of bacterial meningitis and septicaemia worldwide
and is associated with high case fatality rates and serious life-long complications among …

Outer membrane vesicle vaccines

F Micoli, CA MacLennan - Seminars in immunology, 2020 - Elsevier
Abstract Outer Membrane Vesicles (OMV) have received increased attention in recent years
as a vaccine platform against bacterial pathogens. OMV from Neisseria meningitidis …

Outer membrane vesicles as platform vaccine technology

L Van Der Pol, M Stork, P van der Ley - Biotechnology journal, 2015 - Wiley Online Library
Outer membrane vesicles (OMVs) are released spontaneously during growth by many Gram‐
negative bacteria. They present a range of surface antigens in a native conformation and …

Prevention of Neisseria gonorrhoeae With Meningococcal B Vaccine: A Matched Cohort Study in Southern California

KJ Bruxvoort, JA Lewnard, LH Chen… - Clinical Infectious …, 2023 - academic.oup.com
Background Neisseria gonorrhoeae is acquiring increasing resistance to available oral
antibiotics, and current screening and treatment approaches have not decreased gonorrhea …

Outer membrane vesicles (OMVs) produced by gram‐negative bacteria: structure, functions, biogenesis, and vaccine application

N Furuyama, MP Sircili - BioMed Research International, 2021 - Wiley Online Library
Gram‐negative bacteria produce outer membrane vesicles (OMVs) with 10 to 300 nm of
diameter. The contribution of OMVs to bacterial pathogenesis is a topic of great interest, and …

[HTML][HTML] The global evolution of meningococcal epidemiology following the introduction of meningococcal vaccines

SI Pelton - Journal of Adolescent Health, 2016 - Elsevier
Invasive meningococcal disease (IMD) caused by Neisseria meningitidis is associated with
high morbidity and mortality. Although IMD incidence is highest in infants, a second peak …

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 …

RC Read, D Baxter, DR Chadwick, SN Faust, A Finn… - The Lancet, 2014 - thelancet.com
Background Meningococcal conjugate vaccines protect individuals directly, but can also
confer herd protection by interrupting carriage transmission. We assessed the effects of …